Q&A With Labaton Sucharow's Bernard Persky

Law360, New York (October 1, 2007, 12:00 AM EDT) -- A slowdown in pharmaceutical inflation is proof that the antitrust work of plaintiffs firms is benefiting consumers, Bernard Persky of Labaton Sucharow LLP tells Law360 in our series of chats with high-profile practice leaders.

Q. What attracted you to antitrust as a practice area? And what keeps you interested?

A. I was attracted to antitrust as a practice area for primarily two reasons. First, I was drawn to the intellectual rigor and challenges involved in litigating complex legal, factual and economic issues inherent in the practice...
To view the full article, register now.